FI953363A0 - Dimeeriblokkien synteesi ja niiden käyttö oligonukleotidien kokoamisessa - Google Patents

Dimeeriblokkien synteesi ja niiden käyttö oligonukleotidien kokoamisessa

Info

Publication number
FI953363A0
FI953363A0 FI953363A FI953363A FI953363A0 FI 953363 A0 FI953363 A0 FI 953363A0 FI 953363 A FI953363 A FI 953363A FI 953363 A FI953363 A FI 953363A FI 953363 A0 FI953363 A0 FI 953363A0
Authority
FI
Finland
Prior art keywords
dimer blocks
synthesis
oligonucleotide assembly
blocks
dimer
Prior art date
Application number
FI953363A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI953363A (fi
Inventor
Jin Yan Tang
Patricia L Iadarola
Sudhir Agrawal
Original Assignee
Hybridon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybridon Inc filed Critical Hybridon Inc
Publication of FI953363A publication Critical patent/FI953363A/fi
Publication of FI953363A0 publication Critical patent/FI953363A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI953363A 1993-01-08 1995-07-07 Dimeeriblokkien synteesi ja niiden käyttö oligonukleotidien kokoamisessa FI953363A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US282393A 1993-01-08 1993-01-08
PCT/US1994/000296 WO1994015946A1 (fr) 1993-01-08 1994-01-07 Synthese de blocs dimeres et leur utilisation pour l'assemblage d'oligonucleotides

Publications (2)

Publication Number Publication Date
FI953363A FI953363A (fi) 1995-07-07
FI953363A0 true FI953363A0 (fi) 1995-07-07

Family

ID=21702683

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953363A FI953363A0 (fi) 1993-01-08 1995-07-07 Dimeeriblokkien synteesi ja niiden käyttö oligonukleotidien kokoamisessa

Country Status (13)

Country Link
EP (1) EP0678096B1 (fr)
JP (1) JPH08507752A (fr)
KR (1) KR960700262A (fr)
CN (1) CN1122137A (fr)
AT (1) ATE150464T1 (fr)
CA (1) CA2153505A1 (fr)
DE (1) DE69402177T2 (fr)
DK (1) DK0678096T3 (fr)
ES (1) ES2100051T3 (fr)
FI (1) FI953363A0 (fr)
GR (1) GR3023123T3 (fr)
NZ (1) NZ261480A (fr)
WO (1) WO1994015946A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087491A (en) * 1993-01-08 2000-07-11 Hybridon, Inc. Extremely high purity oligonucleotides and methods of synthesizing them using dimer blocks
WO1996029337A1 (fr) * 1995-03-23 1996-09-26 Hybridon, Inc. Phosphorothioates d'oligodesoxynucleotides anti-sens modifies de thiono-triester
US5856464A (en) * 1995-06-07 1999-01-05 Lajolla Pharmaceutical Company Selective capping solution phase oligonucleotide synthesis
US6172217B1 (en) 1996-12-27 2001-01-09 Isis Pharmaceuticals Inc. Method of synthesizing phosphorothioate oligonucleotides
US5902881A (en) * 1997-03-03 1999-05-11 Isis Pharmaceuticals, Inc. Reagent useful for synthesizing sulfurized oligonucleotide analogs
US5760209A (en) * 1997-03-03 1998-06-02 Isis Pharmaceuticals, Inc. Protecting group for synthesizing oligonucleotide analogs
GB9717158D0 (en) * 1997-08-13 1997-10-22 King S College London Solution synthesis of oligonucleotides and their phosphorothioate analogues
US6380378B1 (en) 1998-12-24 2002-04-30 Toagosei Company, Ltd. Nucleotide compound, nucleotide block oligonucleotide, and method for producing them
US6207819B1 (en) * 1999-02-12 2001-03-27 Isis Pharmaceuticals, Inc. Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds
DK1196129T3 (da) 1999-06-25 2006-04-03 Az Univ Amsterdam Farmaceutiske og kosmetiske sammensætninger omfattende urocaninsyrederivater som radikalscavengers eller antioxidanter
CN102344477B (zh) * 2010-07-27 2015-04-08 苏州瑞博生物技术有限公司 一种核苷酸和/或寡核苷酸及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4469863A (en) * 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
DE3332068A1 (de) * 1983-09-06 1985-03-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von nukleosidalkyl-, aralkyl- und arylphosphoniten und -phosphonaten
US4959463A (en) * 1985-10-15 1990-09-25 Genentech, Inc. Intermediates
FR2596761B1 (fr) * 1986-04-08 1988-05-20 Commissariat Energie Atomique Derives de nucleosides et leur utilisation pour la synthese d'oligonucleotides
US5194428A (en) * 1986-05-23 1993-03-16 Worcester Foundation For Experimental Biology Inhibition of influenza virus replication by oligonucleotide phosphorothioates
US5449769A (en) * 1989-03-06 1995-09-12 Gen-Probe Incorporated Method and reagent for sulfurization of organophosphorous compounds
US5003097A (en) * 1989-10-02 1991-03-26 The United States Of America As Represented By The Department Of Health And Human Services Method for the sulfurization of phosphorous groups in compounds
DK0497875T3 (da) * 1989-10-24 2000-07-03 Gilead Sciences Inc 2'-modificerede oligonukleotider
WO1992004358A1 (fr) * 1990-09-04 1992-03-19 Gen-Probe Incorporated Methode et reactif pour la sulfuration de composes organophosphoreux
WO1992020967A1 (fr) * 1991-05-10 1992-11-26 Scholer Incineration Co Pty Ltd Incinerateur
NZ245720A (en) * 1992-01-22 1995-12-21 Hoechst Ag Oligonucleotide analogues; use as gene expression inhibitor or dna probe
RU95104940A (ru) * 1992-07-27 1997-01-10 Хайбрайдон Способ введения в олигонуклеотид алкилфосфонотиоатной или арилфосфонотиоатной межнуклеотидной связи, способ получения олигонуклеотида, олигонуклеотиды, способ ингибирования генной экспрессии, способ лечения

Also Published As

Publication number Publication date
DK0678096T3 (da) 1997-08-18
CA2153505A1 (fr) 1994-07-21
FI953363A (fi) 1995-07-07
AU6024394A (en) 1994-08-15
EP0678096A1 (fr) 1995-10-25
AU673051B2 (en) 1996-10-24
DE69402177T2 (de) 1997-06-26
EP0678096B1 (fr) 1997-03-19
DE69402177D1 (de) 1997-04-24
GR3023123T3 (en) 1997-07-30
KR960700262A (ko) 1996-01-19
CN1122137A (zh) 1996-05-08
ES2100051T3 (es) 1997-06-01
JPH08507752A (ja) 1996-08-20
WO1994015946A1 (fr) 1994-07-21
NZ261480A (en) 1997-05-26
ATE150464T1 (de) 1997-04-15

Similar Documents

Publication Publication Date Title
DE69403642D1 (de) 7-deazapurin modifizierte oligonukleotide
WO1996034107A3 (fr) Proteines antivirales, sequences d'adn codant pour ces proteines et utilisations
FI960089A (fi) Proteiinikinaasi C:n oligonukleotidimodulaatio
AU2836995A (en) Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
EE200000318A (et) Uudsed ühendid
DK1054860T3 (da) Proces for syntesen af 1,3-dioler
IL134042A0 (en) Modified dorsal tissue affecting factor and compositions
DE59507593D1 (de) Gaserzeugendes, azidfreies Stoffgemisch
FI951612A (fi) Menetelmiä synteettisten oligonukleotidien sekvensoimiseksi, jotka sisältävät nukleotidien välisiä ei-fosfodiesterisidoksia
DE69807962D1 (de) Verfahren zur Reinigung von rohem 1,1,1,3,3-Pentafluorpropan
DE69501534D1 (de) Synthese von 1,1,1,3,3-Pentafluorpropan
FI953363A0 (fi) Dimeeriblokkien synteesi ja niiden käyttö oligonukleotidien kokoamisessa
ATE342911T1 (de) Synthese von nukleosiden und polynukleotiden
ATE190352T1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
DK1123414T3 (da) Antisense-modulering af integrin alpha 4.ekspression
ATE284409T1 (de) Synthese von sulfurierten oligonukleotiden
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
ATE144525T1 (de) Bausteine mit carbamate luternukleosidverbindungen und oligonukleotide abgeleitet davon
WO1997003701A3 (fr) Composes et methodes de traitement de cancers lies au recepteur egf et purification du recepteur egf
ATE278702T1 (de) Verfahren zur synthese von phosphorothioat- oligonukelotiden
SE9604582D0 (sv) Novel compounds
AU2866397A (en) Synthesis of 1,1,1-trifluoroethane by fluorination of 1-chloro-1,1-difluoroethane
ATE254627T1 (de) In situ herstellung von nukleosid- phosphoramiditen und ihre verwendung in der oligonukleotidsynthese
SE9603726D0 (sv) Novel compounds
ID27964A (id) Turuna-azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya

Legal Events

Date Code Title Description
FD Application lapsed